CB 2 cannabinoid receptors: New vistas

British Journal of Pharmacology

Volumn 153, Issue 2, 2008, Pages 177-178

  Mackie, K ^a   Ross, R A ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

2AG; AM1241; Anandamide; Cannabinoid; CB 2; GPCR; Knockout; Receptor

Indexed keywords

3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR;

ATHEROSCLEROSIS; BONE DISEASE; DRUG EFFICACY; DRUG TARGETING; GASTROINTESTINAL MOTILITY; IMMUNE SYSTEM; LIVER FIBROSIS; MEDICAL RESEARCH; NONHUMAN; NOTE; PAIN RECEPTOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 38349186328     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707617     Document Type: Note

References (21)

1. 2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol 153: 216-225 (this issue).
2. Bab I, Zimmer A (2008). Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 153: 182-188 (this issue).
3. Buckley N (2008). The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 153: 309-318 (this issue).
4. 2 receptors in the brain: role in central immune function. Br J Pharmacol 153: 240-251 (this issue).
5. 2 receptor. Br J Pharmacol 153: 271-276 (this issue).
6. Fox G, Chin C-L, Tovcimak AE, Hradil VP, Seifert TR, Hollingsworth P et al. (2008). Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Br J Pharmacol 153: 367-379 (this issue).
7. 2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 153: 319-334 (this issue).
8. 2 selective ligands. Br J Pharmacol 153: 335-346 (this issue).
9. 2 receptors as new therapeutic targets during liver diseases. Br J Pharmacol 153: 286-289 (this issue).
10. 2 receptor inverse agonists. Br J Pharmacol 153: 226-239 (this issue).
11. 2 receptors in reproduction. Br J Pharmacol 153: 189-198 (this issue).
12. Mach F, Montecucco F (2008). Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br J Pharmacol 153: 290-298 (this issue).
13. McDougall J, Yu V, Thomson J (2008). In vivo effect of CB2 selective cannabinoids on the vasculature of normal and arthritic rat knee joints. Br J Pharmacol 153: 358-366 (this issue).
14. 2 receptor agonist exhibiting analgesic activity in rodent pain models. Br J Pharmacol 153: 390-401 (this issue).
15. Pacher P, Hasko G (2008). Endocannabinoids and cannabinoid receptors in ischemia-reperfusion injury and preconditioning. Br J Pharmacol 153: 252-262 (this issue).
16. 2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol 153: 347-357 (this issue).
17. 9- tetrahydrocannabivarin. Br J Pharmacol 153: 199-215 (this issue).
18. Rimmerman N, Hughes V, Bradshaw H, Pazas M, Mackie K, Prieto A et al. (2008). Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br J Pharmacol 153: 380-389 (this issue).
19. 2 receptors in human brain inflammation. Br J Pharmacol 153: 277-285 (this issue).
20. 2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 153: 263-270 (this issue).
21. 2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 153: 299-308 (this issue).